Overview of CSU: Prevalence and Presentations

Author(s):

Key Takeaways

CSU primarily affects individuals aged 20-40, with a prevalence of 0.5% to 1% in the general population.
Women are twice as likely to be affected by CSU compared to men.
The condition usually lasts 1 to 5 years, but can persist longer in severe cases.
Clinical manifestations include wheals or hives and angioedema, with symptoms varying significantly among individuals.

Panelists discuss the prevalence and clinical manifestations of chronic spontaneous urticaria (CSU), noting that it primarily affects individuals aged 20 to 40, with a prevalence of 0.5% to 1% in the general population and a higher incidence in women, while also addressing the variability in symptoms such as wheals, hives, and angioedema among patients.

Now Viewing

EP: 1.Overview of CSU: Prevalence and Presentations

EP: 2.Impact of CSU on Patient Quality of Life

EP: 3.Pathophysiology of CSU and Role of BTK

EP: 4.Diagnostic Approach to CSU

EP: 5.Role of Testing in CSU Diagnosis

EP: 6.Referring CSU Patients to a Specialist

EP: 7.Treatment Goals and Guidelines for CSU

EP: 8.Role of Antihistamines, Steroids and Biologics in Treating CSU

EP: 9.Challenges With Current Treatment Options for CSU

EP: 10.Future Landscape of BTK Inhibitors for CSU

EP: 11.Patient Education Tips for CSU and Final Thoughts

Video content above is prompted by the following:

Can you give a general overview of CSU prevalence, clinical manifestations, and common patient characteristics?

Incidence: Peak incidence between 20 and 40 years of age, lasting 1 to 5 years in most patients, but longer in severe cases.
Prevalence: Condition affects between 0.5% and 1% of the general population. Women are affected twice as often as men

How do the wheals/hives and/or angioedema typically appear for patients, and how can these symptoms vary by individual?